Emergency Approval for Zydus Cadila Vaccine for Children 12+
The war with Corona in the whole world is not over yet. Another vaccine has arrived in the midst of the war caused by this epidemic. The vaccine is also approved for children over the age of 12. The Drug Controller General of India has allowed emergency use of the Zydus Cadila vaccine. This is the world’s first Kovid-19 vaccine made in India which is based on DNA. Apart from adults, this vaccine will also be given to children above 12 years of age.
Zycox-D will be the world’s first DNA vaccine against coronavirus which has been developed by an Indian company. In such a situation, after Serum Institute’s Covishield, Bharat Biotech’s Covacin, Russia’s Sputnik-V, Moderna, and Johnson & Johnson’s vaccine, five vaccines will be approved in the country. According to the information, generic drug company Cadila Healthcare Limited has approved only emergency use of ZyCoV-D. The company had applied on July 1 last. Zyndus Cadila had an effect of 66.6 percent on about 280,000 volunteers. According to the information, this is the first plasma DNA vaccine to fight the coronavirus. In this, the genetic elements of the virus are used. They transmit information to DNA or RNA to make proteins and enhance the immune system.
All three vaccines currently being administered in India are double-dose. The Johnson & Johnson and Sputnik Lite JC single-dose vaccines may arrive in India in the coming months, but the Zykov-D vaccine is different from all these. Three doses of this vaccine will be given.
So far five vaccines have been approved
Let us tell you that the vaccination campaign in the country started on 16 January 2021. Since then, the use of five vaccines has been approved. Zydus Cadila vaccine is the fifth vaccine. Earlier, four other vaccines that have been approved for emergency use include Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik B, and US-made Moderna.